President Trump displayed a Washington Post headline announcing the sharpest drop in prescription drug prices in more than 60 years during a Friday photo opportunity with reporters. The White House subsequently shared images of Trump holding the article’s headline across its official social media accounts, with press secretary Karoline Leavitt amplifying the post. Trump read portions of the headline aloud and stated he had predicted the development, gesturing broadly to suggest credit for the accomplishment.
However, the full text of the Post article, published on Thursday, reported that independent health economists attributed the price decline primarily to a Biden administration policy rather than Trump initiatives. According to the article, the Inflation Reduction Act, enacted in 2022, required Medicare to negotiate prices for prescription drugs, with the first reductions taking effect earlier this year. Richard Frank, a health economics professor emeritus at Harvard University, expressed skepticism that Trump policies drove the decline, stating he would attribute the drop to aspects of the Biden-era legislation.
Stacie Dusetzina, a health policy professor at Vanderbilt University, similarly told the Post that the Biden law was a more probable explanation for falling drug prices than Trump administration efforts. The article noted that while approximately 10 drugs have had prices negotiated under the Inflation Reduction Act framework, they are widely prescribed medications whose price changes would likely be reflected in overall drug price indices.
Consumer Price Index data released by the Bureau of Labor Statistics showed prescription drug prices fell 3.1 percent in July. White House communications director Steven Cheung posted the headline screenshot on social media without including a link to the full article, crediting Trump for the development.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI